Abstract
Objective To detect potential hotspots of transmission of dengue and chikungunya in Barbados, and assess impact of input surveillance data and methodology on observed patterns of risk.
Methods Using two methods of cluster detection, Moran’s I and spatial scan statistics, we analyzed the geospatial and temporal distribution of disease cases and rates across Barbados for dengue fever in 2013–2016, and a 2014 chikungunya outbreak.
Results During years with high numbers of dengue cases, hotspots for cases were found with Moran’s I in south and central regions in 2013 and 2016, respectively. Using smoothed disease rates, clustering was detected every year for dengue. Hotspots were not detected via spatial scan statistics, but coldspots suggesting lower rates of disease activity were found in southwestern Barbados during high case years of dengue.
Conclusions Spatial analysis of surveillance data is useful in identifying outbreak hotspots, complementing existing early warning systems. We caution that these methods should be used in a manner appropriate to available data, and reflecting explicit public health goals – managing for overall case numbers, or targeting anomalous rates for further investigation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
This study was solicited by the Caribbean Institute for Meteorology and Hydrology (CIMH) through the United States Agency for International Development’s (USAID, Grant ID: AID-538-10-14-00001) Programme for Building Regional Climate Capacity in the Caribbean (BRCCC Programme: rcc.cimh.edu.bb/brccc) with funding made possible by the generous support of the American people. RL was funded by a Royal Society Dorothy Hodgkin Fellowship.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the MoH, Barbados, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the MoH, Barbados.
